Related Experiment Video
Updated: Aug 14, 2026

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Pharmacologic advances in the systemic treatment of itch
Brett T Summey1, Gil Yosipovitch
1Department of Dermatology and Neuroscience Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA.
Abstract:
Itch is propagated by complex mechanisms located both peripherally and within the central nervous system. For decades, novel treatments of itch have been slow to emerge, with the majority of focus on antagonism of histamine. Recently, with a new understanding of the pathophysiology of itch transmission, new treatment strategies have been elucidated. Opiate receptor antagonists, antidepressants, antiepileptics, and thalidomide are currently available therapeutic options that have benefited many patients with variegated sources of itch. In addition, research focused on the neuromediators of itch transmission has led to the development of novel targets for itch reduction and great potential for future therapies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Anthelminthic Agents
Drug Therapy
Antianxiety Medications
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Cholinergic Antagonists: Pharmacokinetics